|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-9-22
|
|
pubmed:abstractText |
To determine how well the current Pharmaceutical Benefits Scheme (PBS) eligibility criteria for subsidy of lipid-lowering drugs compare with current national guidelines for determining the population at high risk of developing cardiovascular disease (CVD).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0025-729X
|
|
pubmed:author |
pubmed-author:BoydenAndrew NAN,
pubmed-author:CadilhacDominique ADA,
pubmed-author:ChenLeiL,
pubmed-author:ColagiuriStephenS,
pubmed-author:MaglianoDianna JDJ,
pubmed-author:MathewTimothy HTH,
pubmed-author:National Vascular Disease Prevention Alliance,
pubmed-author:PeetersAnnaA,
pubmed-author:RogersSophie LSL,
pubmed-author:ShawJonathan EJE,
pubmed-author:TonkinAndrew MAM,
pubmed-author:ZimmetPaul ZPZ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
189
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
319-22
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18803535-Adult,
pubmed-meshheading:18803535-Aged,
pubmed-meshheading:18803535-Australia,
pubmed-meshheading:18803535-Cardiovascular Diseases,
pubmed-meshheading:18803535-Cross-Sectional Studies,
pubmed-meshheading:18803535-Diabetes Complications,
pubmed-meshheading:18803535-Female,
pubmed-meshheading:18803535-Guideline Adherence,
pubmed-meshheading:18803535-Humans,
pubmed-meshheading:18803535-Hypolipidemic Agents,
pubmed-meshheading:18803535-Male,
pubmed-meshheading:18803535-Metabolic Syndrome X,
pubmed-meshheading:18803535-Middle Aged,
pubmed-meshheading:18803535-Physician's Practice Patterns,
pubmed-meshheading:18803535-Practice Guidelines as Topic,
pubmed-meshheading:18803535-Risk Assessment
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
How do the Australian guidelines for lipid-lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999-2000.
|
|
pubmed:affiliation |
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
